Gerard Cunningham joined Adjuvant Capital in 2020 as an Operating Partner following his five-year role as Senior Advisor to the Global Health Investment Fund. While at GHIF, he supported investments in several companies including the fund’s investments in EuBiologics and Univercells and has been deeply involved in diligence and technical assistance activities for the portfolio companies of both funds .

Before his roles with GHIF and Adjuvant Capital, Gerard worked for the Bill & Melinda Gates Foundation Vaccine Delivery team and Merck Vaccines, where he led New Product Planning. Gerard earned MA and MEng degrees from the University of Cambridge and an MBA from the Ross School of Business at the University of Michigan.